Entera Bio Ltd. (ENTX)

CIK 1638097 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Entera Bio Ltd..

Recent SEC filings

FiledFormAccession number
Oct 30, 2026SCHEDULE 13G0001738048-26-000079
Oct 27, 20268-K0001178913-26-004854
Oct 14, 2026DEF 14A0001178913-26-004771
Oct 6, 20268-K0001178913-26-004720
Sep 23, 2026PRE 14A0001178913-26-004572
Aug 28, 2026424B30001178913-26-004301
Aug 28, 2026EFFECT9999999995-26-002813
Aug 21, 2026S-30001178913-26-004221
Aug 21, 202630001178913-26-004216
Aug 18, 20268-K0001178913-26-004178
Aug 12, 2026D0001638097-26-000003
Aug 7, 202640001178913-26-003956
Aug 7, 20268-K0001178913-26-003946
Aug 7, 202640001178913-26-003952
Aug 7, 202640001178913-26-003955
Aug 7, 202640001178913-26-003957
Aug 7, 202640001178913-26-003954
Aug 7, 202640001178913-26-003949
Aug 7, 202610-Q0001178913-26-003947
Aug 7, 2026S-80001178913-26-003948
Aug 7, 202640001178913-26-003950
Aug 7, 202640001178913-26-003951
Aug 7, 202640001178913-26-003953
Aug 4, 2026SCHEDULE 13D0000921895-26-001957
Aug 4, 2026SCHEDULE 13G0001193125-26-333432